Wenhui Zhu | Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy

Norwalk Hospital - Yale University

Residency

National Institutes of Health Clinical Center

Fellowship

Hunan Medical University

Medical School

OH State Medical License Active through 2013

American Board of Internal Medicine

American Board of Internal Medicine - Hematology

American Board of Internal Medicine - Oncology

Isoflurane preconditioning neuroprotection in experimental focal stroke is androgen-dependent in male mice.

Zhu, W.,Wang, L.,Zhang, L.,Palmateer, J. M.,Libal, N. L.,Hurn, P. D.,Herson, P. S.,Murphy, S. J.; Neuroscience. 2010 Jun 29.

Tumor angiogenesis as an early marker of long-term prostate cancer mortality.

Zhu, W.,Dahut, W. L.; Future Oncol. 2010 Mar 13.

Treatment of castration-resistant prostate cancer: updates on therapeutics targeting the androgen receptor signaling pathway.

Zhu, W.,Zhu, D. S.,Madan, R. A.,Gulley, J. L.,Figg, W. D.,Dahut, W. L.; Am J Ther. 2009 Dec 19.

Education & Training

Norwalk Hospital - Yale University
Residency
National Institutes of Health Clinical Center
Fellowship
Hunan Medical University
Medical School
Board Certifications

American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
Publications & Memberships

Dr. Wenhui Zhu has contributed to 3 publications.

Isoflurane preconditioning neuroprotection in experimental focal stroke is androgen-dependent in male mice.

Zhu, W.,Wang, L.,Zhang, L.,Palmateer, J. M.,Libal, N. L.,Hurn, P. D.,Herson, P. S.,Murphy, S. J.; Neuroscience. 2010 Jun 29.
See more >>

Tumor angiogenesis as an early marker of long-term prostate cancer mortality.

Zhu, W.,Dahut, W. L.; Future Oncol. 2010 Mar 13.
See more >>

Treatment of castration-resistant prostate cancer: updates on therapeutics targeting the androgen receptor signaling pathway.

Zhu, W.,Zhu, D. S.,Madan, R. A.,Gulley, J. L.,Figg, W. D.,Dahut, W. L.; Am J Ther. 2009 Dec 19.
See more >>